Article
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Learning at the Rate of Evidence: How AI Is Reshaping R&D at Pfizer
By Chris Boshoff, MD, PhD, FMedSciChief Scientific Officer and President, Research & Development, Pfizer Artificial intelligence (AI) has great potential to transform the timeline from an idea to a medicine or vaccine. At Pfizer, we are building an AI-native R&D organization, one where AI is built into the entire R&D process: target and molecule discovery, preclinical toxicology, clinical study product manufacturing, clinical development, medical affairs, regulatory, pharmacovigilance and...
Why Cancer Patients Are Prime Targets for Drug Counterfeiters
All fake drugs pose a risk to public health. Although they’re designed to look legitimate, they’re made in unsafe and unsanitary conditions. Beyond simply not working, they can lead to treatment failures or, in the worst case, death. For patients living with cancer, though, a mix of intersecting clinical and market dynamics make counterfeit oncology medication especially dangerous — and especially profitable for global criminal trafficking networks.“It’s easy to see that the climate is ripe for...
Set Point Theory: Why the Body Fights to Regain Lost Weight
Managing obesity isn’t just about losing weight—it’s also about keeping it off. That’s a difficult prospect for many, but not because of a lack of discipline. The body is biologically designed to resist sustained weight loss.Obesity is a complex, chronic disease. Once viewed simply as a matter of willpower, researchers now know obesity is influenced by complex biological processes that regulate hunger, energy use, and body weight. One of the most important concepts behind this understanding is...
Season 7 of Science Will Win Podcast Tackles Obesity
For six seasons, the Science Will Win podcast has tackled topics at the forefront of healthcare and science. Pfizer’s flagship podcast is dedicated to educating and informing listeners with help from the doctors on the front lines, the scientists behind the scenes, and the patients and survivors looking for help – and hope... Thanks to its compelling mix of expert information, scientific insight, and personal perspectives, the award-winning Science Will Win ranks among the top 1% of all podcasts...
Pfizer's Third-Quarter Results Reflect Confidence and Momentum
Pfizer reported third-quarter 2026 results on November 3 that exceeded the company’s expectations. The company’s commercial performance globally and continued financial discipline led to it raising its financial outlook for the year. With commercial momentum building and a robust slate of expected catalysts ahead, the company is focused on returning to growth toward the end of the decade.See below for key highlights. More details on Pfizer’s third-quarter 2026 earnings results and financial...
October Social Media Round-Up—Science Will Win, Values Day, and More
The seasons are changing and the weather is getting cooler, but our social media round-up is hot off the presses. As usual, we are sharing the latest and greatest updates from the last month. In October, we teased the launch of the next season of our award-winning podcast "Science Will Win," celebrated Pfizer's inclusion in Fortune's AIQ 75 list, and lit up our global offices for Light Up MBC. CEO Albert Bourla celebrated Values Day at Pfizer and his induction into the American Academy of Arts...
Born in Brooklyn: Celebrating Nearly 180 Years of American Innovation
As the United States celebrates its 250th anniversary this year, Pfizer is reflecting on its own place in America’s long history of innovation and looking ahead to the next wave of discoveries we aim to achieve.Founded in Brooklyn, New York, in 1849, Pfizer began with two entrepreneurs and a commitment to applying science to improve people’s lives. Nearly 180 years later, Pfizer colleagues continue to build on that legacy, advancing science with the potential to make a difference for people...
Looking Beyond Weight Loss: The Future of Obesity Care
As the understanding of obesity science evolves, focus is shifting from simply reducing body weight to treating obesity as a complex, chronic disease affecting almost every system of the body. Along with new therapies, a growing understanding of obesity’s biological underpinnings is changing how healthcare professionals think about treatment, long-term health, and the future of personalized care.While traditionally viewed as a matter of personal responsibility, scientists now believe obesity is...
How Pfizer Is Rethinking What’s Possible in Cancer Care
For people living with cancer and those who love them, every moment matters. Cancer remains one of the greatest healthcare challenges of our lifetime, and Pfizer is working with urgency to transform scientific advances into potential life-changing medicines.In a sponsored interview, Jeff Legos, Pfizer’s Chief Oncology Officer, sat down with Jessica Sibley, CEO of TIME, to discuss why this mission is personal for him, the responsibility he feels as Pfizer works toward its ambition of delivering...
Pfizer Learns to Speak AI with Fluency Program
Technology moves fast, and there’s no better example than the rapid growth of artificial intelligence (AI).Here at Pfizer, we have long been focused on making breakthroughs that change patients’ lives. As new technology like AI emerges that can help us pursue our goals, we are committed to learning how best to apply AI to help make those breakthroughs even more quickly and efficiently. CEO Albert Bourla is leading the way with his vision for the future of Pfizer. His goal is to leverage AI...
Rewriting the Obesity Narrative
Over millions of years, humans got remarkably good at storing excess energy as fat. To survive perilous stretches of scarcity and famine, our brains evolved to view calorie-dense foods as highly rewarding, and our biology encourages us to eat as much as possible when we encounter them.Fast forward to the modern world, and those kinds of foods are much more readily available, but our brains’ regulatory mechanisms never caught up.1 What was once an evolutionary advantage now works against us. The...
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission
In 2013, Josh Raub’s life was going according to plan. At 29 years old, he was working at his dream job as a professor and pharmacy specialist at an academic medical center in Detroit. He and his wife had just bought their first home and were talking about starting a family. “It was just this perfect future that we were planning for ourselves,” he says.Then he got sick. It didn’t seem like much at first: a low-grade fever, night sweats, fatigue. He thought it might be the flu. He’d get better...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.